🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Elimination

According to TikTok, the service has removed problematic material and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the service safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also discovered communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence.

Within moments of entering one community, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Inside these groups, posts show black plastic packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram said it actively monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has previously encountered patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially significant health risks”.